This site is under development. For the current active site, go to bcbhub.csic.es.

Orcid Publication

Detalle de: Selective Pressure by Rifampicin Modulates Mutation Rates and Evolutionary Trajectories of Mycobacterial Genomes

Title Selective Pressure by Rifampicin Modulates Mutation Rates and Evolutionary Trajectories of Mycobacterial Genomes
Abstract

Rifampicin is the most important first-line antibiotic against mycobacterial infections, including tuberculosis, one of the top causes of death worldwide. Acquisition of rifampicin resistance constitutes a major global public health problem that makes the control of the disease challenging.

Apa Reference Cebrián-Sastre, E., Chiner-Oms, A., Torres-Pérez, R., Comas, I., Oliveros, J.C., Blázquez, J. & Castañeda-García, A. (2023). Selective Pressure by Rifampicin Modulates Mutation Rates and Evolutionary Trajectories of Mycobacterial Genomes. Microbiology Spectrum, 11(4). 10.1128/spectrum.01017-23
Doi 10.1128/spectrum.01017-23
Publication Date 17 Aug 2023
Publication Type Article
Researcher Álvaro Chiner-Oms
Ontology Evolutionary rates
Research Groups
Tools

Suggest changes

Publications are synced automatically from ORCID, so they can't be edited here directly. Spotted something wrong? Let us know below and we'll take care of it.

← Return to Home